Background: Africans have an increased risk for multiple myeloma (MM) compared to other
races. Reports from Africa are few and involve small cohorts, but suggest significant …

Background Multiple myeloma (MM) is one of the hematological malignancies that require
palliative care. This is because of the life-threatening nature and the suffering associated …

Aim: In developing African nations, late presentation and occurrence of complications
adversely affects survival. This study aims at identifying initial clinical and basic laboratory …

Haematological malignancies are major cause of mortality and morbidity worldwide. The
aim of this review was to summarize some of the challenges that hamper proper diagnosis …

PURPOSE This study sought to delineate the clinical, laboratory, and imaging
characteristics during multiple myeloma (MM) diagnosis, outline the treatment modalities …

Purpose Novel therapy has dramatically changed the outcome of patients with myeloma.
Current National Comprehensive Cancer Network guidelines give bortezomib-based …

Multiple myeloma (MM) is one of the commonest hematological malignancies of public
health importance especially in low-income countries (LICs) of Sub-Saharan Africa. The two …

Background: Abnormal plasma cells in multiple myeloma produce excessive amounts of
immunoglobulins and free light chains, of which certain patterns predict patient survival …

OBJECTIVE: To analyze the clinical and laboratory features of Multiple Myeloma at
presentation in a tertiary centre in Port Harcourt, Southern Nigeria. METHODS: The medical …

Palliative Care is an intervention which improves the quality of life of those suffering from
lifethreatening illnesses. MM is one of the hematologic malignancies that require palliative …